Figure 3.
![Adapted from [60] with permission, future requests for reproduction should be made to Elsevier (https://jpharmsci.org/article/S0022-3549(15)00066-0/fulltext).](https://port.silverchair-cdn.com/port/content_public/journal/biochemsoctrans/49/4/10.1042_bst20210168/1/bst-2021-0168c.03.png?Expires=1717047835&Signature=Ugp0rw0MH5x-s9RvlVN-02zelNrt-5lZAguD-tkeO6E2ew1ibq562dzDCdkqAPY6ZkWfyubpFB81~KQV3WD63bfDLEdbnPTE6KJ1-rjz9vt-hWNet5pgB~E0qT4~puBEClJ1P3aeoUitBaAESy3kpdiSHBooSeBD7p~wLdhVU1YhQkgFiqwWQdVw9yrO0o25~klY9-e5-jLBQzUaqqjGl3rjRrbEXnRGvAyw~xuinx5b1UmpIU-0y47AX0uwgYeqSQP9goVVTBa5xiZKwApYmUI35a5wuAuXthTtJoThEwsOw4EEmMHxnaZp0RIQ4DkYqMULUoICtRW5sbFNKuSu4Q__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
(left) Configuration for in situ X-ray scattering measurements during digestion of a self-nano-emulsifying drug delivery system (SNEDDS) and (right) the appearance of diffraction peaks signifying the crystallisation of fenofibrate during digestion of a formulation.
Adapted from [60] with permission, future requests for reproduction should be made to Elsevier (https://jpharmsci.org/article/S0022-3549(15)00066-0/fulltext).